Drugs (Prices Control) Order, 1995

The Supreme Court examined the validity of several notifications issued by the Central Government under the Drugs (Prices Control) Order, 1995 (DPCO 1995) that prescribed norms for conversion cost, packing charges and process loss, and fixed retail or ceiling prices of drug formulations. The Court held that the 1999 no…

GlaxoSmithKline Pharmaceuticals Ltd challenged notices issued by the Drug Inspector after a price‑fixation notification under the Drugs (Prices Control) Order, 1995. The issue was whether the notified ceiling price became operative for all sales immediately, or whether manufacturers could continue to sell pre‑notificat…

The Union of India challenged the Delhi High Court's order setting aside price‑fixation notifications for Doxofylline formulations, arguing that Doxofylline is a derivative of the scheduled bulk drug Theophylline. The respondents contended that Doxofylline is a new chemical entity not listed in the First Schedule of th…